Dinh Thi Hong Nhung, PhD
Research Insitute of Stem Cell and Gene Therapy
Medical Specialist
Biography
Dr. Dinh Thi Hong Nhung earned her PhD in Life Sciences from the Pohang University of Science and Technology (POSTECH), South Korea in 2020. Her research focuses on exosomes and extracellular vesicles (EVs) – a rapidly growing field in regenerative medicine. Dr. Nhung has published in high-impact scientific journals, including Nature Communications, Biomaterials, and the Journal of Extracellular Vesicles. Her pioneering study on bacterial EV–based cancer therapy, published in Nature Communications with >500 citations, laid the groundwork for establishing Rosetta Exosomes Inc. in South Korea, where she contributed as a key member of the R&D team. In 2022, Dr. Nhung joined the Vinmec Stem Cell and Gene Technology Research Institute (VRISG). She leads projects on EV-based therapies for degenerative diseases and MSC-derived EVs for clinical applications, aiming to translate cutting-edge EV science into therapeutic reality.
Exosomes/EV for diagnosis and treatment of cancer or degenerative disease
1. Dinh NTH, Nguyen QT, Hang NT, Dao HN, Son LD, Ngan GT, et al. Assessment of the safety of hypoxia-primed mesenchymal stem cells derived from umbilical cord and adipose tissues in animals. Sci Rep. 2025 Oct 15;15(1):36055.
2. Hoang VT, Nguyen QT, Phan TTK, Pham TH, Dinh NTH, Anh LPH, et al. Tissue Engineering and Regenerative Medicine: Perspectives and Challenges. MedComm. 2025;6(5):e70192.
3. Dinh NTH, Lee J, Lee J, Kim SS, Go G, Bae S, et al. Indoor dust extracellular vesicles promote cancer lung metastasis by inducing tumour necrosis factor-α. J Extracell Vesicles. 2020;9(1):1766821.
4. Kim OY*, Park HT*, Dinh NTH*, Choi SJ, Lee J, Kim JH, et al. Bacterial outer membrane vesicles suppress tumor by interferon-γ-mediated antitumor response. Nat Commun. 2017 Sep 20;8(1):626. (*equal contribution)
5. Kim OY*, Dinh NTH*, Park HT, Choi SJ, Hong K, Gho YS. Bacterial protoplast-derived nanovesicles for tumor targeted delivery of chemotherapeutics. Biomaterials. 2017 Jan;113:68–79. (*equal contribution)
– PhD degree: Life sciences – 02/2020, POSTECH, South Korea
– Bachelor’s degree: Biotechnology – 09/2011, National University of Sciences, Vietnam